Compare NTRS & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTRS | LH |
|---|---|---|
| Founded | 1889 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3B | 21.4B |
| IPO Year | N/A | N/A |
| Metric | NTRS | LH |
|---|---|---|
| Price | $139.01 | $265.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $127.77 | ★ $299.00 |
| AVG Volume (30 Days) | ★ 925.1K | 792.0K |
| Earning Date | 01-22-2026 | 10-28-2025 |
| Dividend Yield | ★ 2.33% | 1.10% |
| EPS Growth | 7.22 | ★ 98.36 |
| EPS | 8.58 | ★ 10.19 |
| Revenue | $7,932,900,000.00 | ★ $13,765,300,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | $4.02 | $4.44 |
| P/E Ratio | ★ $16.00 | $25.72 |
| Revenue Growth | 0.96 | ★ 8.28 |
| 52 Week Low | $81.62 | $209.38 |
| 52 Week High | $137.69 | $293.72 |
| Indicator | NTRS | LH |
|---|---|---|
| Relative Strength Index (RSI) | 73.18 | 51.50 |
| Support Level | $132.24 | $256.30 |
| Resistance Level | $133.80 | $272.82 |
| Average True Range (ATR) | 2.45 | 4.81 |
| MACD | 0.91 | -0.00 |
| Stochastic Oscillator | 96.11 | 54.48 |
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.